Macquarie Group
CDNA icon

Macquarie Group’s CareDx CDNA Stock Holding History

Macquarie Group’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-462,952
Closed -$6.73M – 973
2025
Q3 		$6.73M Sell
462,952
-50,815
-10% -$724K 0.01% 891
2025
Q2 		$10M Sell
513,767
-48,072
-9% -$854K 0.01% 814
2025
Q1 		$9.97M Buy
561,839
+120,632
+27% +$2.6M 0.01% 805
2024
Q4 		$9.45M Buy
+441,207
New +$10.7M 0.01% 815
2023
Q1 		– Sell
-882,664
Closed -$10.1M – 1712
2022
Q4 		$10.1M Sell
882,664
-719,373
-45% -$10.7M 0.01% 835
2022
Q3 		$27.3M Sell
1,602,037
-342,981
-18% -$7.36M 0.03% 608
2022
Q2 		$41.8M Buy
1,945,018
+237,381
+14% +$6.58M 0.05% 516
2022
Q1 		$63.2K Buy
1,707,637
+83,575
+5% +$3.26M 0.05% 444
2021
Q4 		$73.9M Sell
1,624,062
-12,316
-0.8% -$643K 0.06% 396
2021
Q3 		$104M Buy
1,636,378
+193,535
+13% +$14.7M 0.09% 289
2021
Q2 		$132M Buy
1,442,843
+1,440,526
+62,172% +$115M 0.11% 234
2021
Q1 		$158K Buy
2,317
+70
+3% +$5.43K ﹤0.01% 1777
2020
Q4 		$162K Buy
2,247
+920
+69% +$53.3K ﹤0.01% 1736
2020
Q3 		$50K Hold
1,327
– – ﹤0.01% 1954
2020
Q2 		$47K Buy
+1,327
New +$37.8K ﹤0.01% 1943
2020
Q1 		– Sell
-65,323
Closed -$1.41M – 1968
2019
Q4 		$1.41M Sell
65,323
-13,186
-17% -$303K ﹤0.01% 1141
2019
Q3 		$1.77M Buy
78,509
+36,779
+88% +$1.02M ﹤0.01% 1063
2019
Q2 		$1.5M Sell
41,730
-3,414
-8% -$109K ﹤0.01% 1100
2019
Q1 		$1.42M Sell
45,144
-4,847
-10% -$141K ﹤0.01% 1086
2018
Q4 		$1.26M Sell
49,991
-700
-1% -$18K ﹤0.01% 1086
2018
Q3 		$1.46M Buy
50,691
+29,391
+138% +$550K ﹤0.01% 1105
2018
Q2 		$261K Sell
21,300
-57,700
-73% -$662K ﹤0.01% 1573
2018
Q1 		$630K Buy
79,000
+53,100
+205% +$327K ﹤0.01% 1314
2017
Q4 		$190K Buy
+25,900
New +$161K ﹤0.01% 1742

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Macquarie Group's CDNA Position: Q4 2025 in Review

Macquarie Group sold out of CareDx (CDNA) in Q4 2025, closing a stake of 462,952 shares — an estimated $6.73M sold.

Macquarie Group first reported a position in CDNA in Q4 2017 and held it in 24 quarters. The position peaked at $132M in Q2 2021. 200 funds tracked by Wall St. Rank hold CDNA as of Q4 2025.

  • Macquarie Group reported no remaining CareDx position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 462,952 CareDx shares in Q4 2025, an estimated $6.73M.
  • Macquarie Group first reported a position in CareDx in Q4 2017 and held it in 24 quarters.
  • Macquarie Group's CareDx position peaked at $132M in Q2 2021.
  • 200 funds tracked by Wall St. Rank held CareDx as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.